Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

BACKGROUND: 5-Fluorouracil (5FU), Folinic acid (FA), and Oxaliplatin (FOLFOX) or 5FU, FA, and Irinotecan (FOLFIRI) are standard regimens for palliative chemotherapy of metastatic colon cancer. Since data showing the influence of dose reduction in palliative treatment are rare, the objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Munker, Stefan, Gerken, Michael, Fest, Petra, Ott, Claudia, Schnoy, Elisabeth, Fichtner-Feigl, Stefan, Wiggermann, Philipp, Vogelhuber, Martin, Herr, Wolfgang, Stroszczynski, Christian, Schlitt, Hans Jürgen, Evert, Matthias, Reng, Michael, Klinkhammer-Schalke, Monika, Teufel, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913883/
https://www.ncbi.nlm.nih.gov/pubmed/29685155
http://dx.doi.org/10.1186/s12885-018-4380-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913883/
https://www.ncbi.nlm.nih.gov/pubmed/29685155
http://dx.doi.org/10.1186/s12885-018-4380-z

Ejemplares similares